Clinical Trial Update: CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating 0.2% Aetoxysklerol foam with 70% glucose for treating lower limb telangiectasias; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reticular Veins
• Spider Veins
• Varicose Veins of the Lower Limb

Drugs mentioned

• Aetoxysklerol Foam (0.2%) (polidocanol)
• Glucose 70% solution (glucose)

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Varicose Veins of Lower Limb, Spider Veins | Phase 2 | Status: NOT_YET_RECRUITING